Clinical bottom line
Artificial intelligence (AI)-enhanced imaging modalities show promising potential for the early detection and screening of cardiac valvular disease by improving diagnostic accuracy and efficiency. Current evidence suggests that AI integration with echocardiography, cardiac CT, and auscultation can augment traditional imaging interpretation, potentially enabling earlier identification of valvular abnormalities before clinical symptoms manifest. However, these findings remain preliminary and warrant further validation in diverse clinical populations and prospective studies. Radiologists should remain informed about evolving AI tools but continue to rely on established imaging protocols and clinical correlation until robust evidence supports widespread adoption.
What the evidence shows
Cardiac valvular disease, encompassing conditions such as aortic stenosis and mitral regurgitation, remains a significant cause of morbidity and mortality worldwide. Conventional imaging techniques including echocardiography, cardiac CT, and MRI are central to diagnosis and management (Abbara et al., 2016; Ataya et al., 2012). Recent advances have explored the integration of AI algorithms to enhance image acquisition, interpretation, and screening workflows.
AI-enhanced auscultation devices, which combine digital stethoscope recordings with machine learning algorithms, have demonstrated improved sensitivity and specificity for detecting valvular murmurs compared to traditional auscultation by clinicians (Palmer et al., 2026). This technology may facilitate earlier screening in primary care or sports cardiology settings, where subtle valvular disease is often missed (Jalkh et al., 2026).
In cardiac CT, AI applications have been developed to automate valve morphology assessment and quantify calcification burden, improving reproducibility and potentially identifying early structural changes indicative of valvular pathology (Ataya et al., 2012). Similarly, AI-driven image segmentation and pattern recognition in echocardiography can aid in detecting subtle leaflet abnormalities and functional impairment before overt clinical signs arise.
Despite these advances, the majority of current evidence derives from pilot studies or retrospective analyses with limited sample sizes. There is a paucity of large-scale prospective trials validating AI-enhanced imaging for routine clinical screening or early diagnosis of valvular heart disease. Furthermore, integration of AI tools into clinical workflows and their impact on patient outcomes remain underexplored.
Caveats and uncertainty
Several important limitations temper enthusiasm for immediate clinical implementation of AI-enhanced imaging in valvular disease detection:
- Heterogeneity of AI models: Many AI algorithms are developed on single-center datasets, raising concerns about generalizability across diverse populations and imaging platforms.
- Limited prospective validation: Most studies are retrospective or proof-of-concept, lacking rigorous prospective validation to confirm diagnostic accuracy and clinical utility.
- Interpretability and regulatory approval: The "black box" nature of some AI models complicates clinical acceptance, and regulatory pathways for approval remain evolving.
- Integration challenges: Workflow integration, training requirements, and cost-effectiveness analyses are insufficiently addressed in current literature.
- Clinical impact unknown: It remains unclear whether earlier detection via AI-enhanced imaging translates into improved clinical outcomes, such as reduced progression or better surgical timing.
Therefore, while AI-enhanced imaging is a promising adjunct, it should not replace comprehensive clinical evaluation and established imaging protocols at this stage.
How this may change practice
As AI tools mature and undergo robust validation, they may become valuable adjuncts in radiology and cardiology practices by:
- Enhancing screening sensitivity: AI-enhanced auscultation and imaging could identify valvular abnormalities earlier in asymptomatic or at-risk populations, prompting timely referral.
- Improving diagnostic accuracy: Automated quantification and pattern recognition may reduce interobserver variability and improve detection of subtle valvular changes.
- Optimizing workflow: AI could streamline image analysis, allowing radiologists to focus on complex cases and reduce reporting times.
- Personalizing management: Integration with clinical data and imaging biomarkers may enable risk stratification and tailored surveillance strategies.
However, adoption should be cautious and evidence-based, with multidisciplinary collaboration to ensure AI tools complement rather than supplant clinical judgment.